Beneficial Effects of Adenylyl Cyclase Type 6 (AC6) Expression Persist Using a Catalytically Inactive AC6 Mutant
- 2 December 2010
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 79 (3), 381-388
- https://doi.org/10.1124/mol.110.067298
Abstract
Cardiac-directed expression of AC6 has pronounced favorable effects on cardiac function possibly not linked with cAMP production. To determine rigorously whether cAMP generation is required for the beneficial effects of increased AC6 expression, we generated a catalytically inactive AC6 mutant (AC6mut) that has markedly diminished cAMP generating capacity by replacing aspartic acid with alanine at position 426 in the C1 domain (catalytic region) of AC6. Gene transfer of AC6 or AC6mut (adenovirus-mediated) in adult rat cardiac myocytes resulted in similar expression levels and intracellular distribution, but AC6mut expression was associated with marked reduction in cAMP production. Despite marked reduction in cAMP generation, AC6mut influenced intracellular signaling events similarly to that observed after expression of catalytically intact AC6. For example, both AC6 and AC6mut reduced phenylephrine-induced cardiac myocyte hypertrophy and apoptosis (p < 0.001), expression of cardiac ankyrin repeat protein (p < 0.01), and phospholamban (p < 0.05). AC6mut expression, similar to its catalytically intact cohort, was associated with increased Ca2+ transients in cardiac myocytes after isoproterenol stimulation. Many of the biological effects of AC6 expression are replicated by a catalytically inactive AC6 mutant, indicating that the mechanisms for these effects do not require increased cAMP generation.Keywords
This publication has 51 references indexed in Scilit:
- Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by α-crystallin-BProceedings of the National Academy of Sciences of the United States of America, 2010
- β1-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: Differences in transgene localization and intracellular signalingCellular Signalling, 2010
- Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female MiceJournal of the American College of Cardiology, 2010
- Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6Biochemical and Biophysical Research Communications, 2009
- Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac MyocytesPublished by Elsevier BV ,2008
- Activation of Cardiac Adenylyl Cyclase Expression Increases Function of the Failing Ischemic Heart in MiceJournal of the American College of Cardiology, 2008
- Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial InfarctionCirculation, 2006
- Intracoronary Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function in Heart FailureCirculation, 2004
- Cardiac Ankyrin Repeat Protein Is a Novel Marker of Cardiac HypertrophyHypertension, 2000
- Overexpression of Gs alpha protein in the hearts of transgenic mice.JCI Insight, 1995